Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 1001-1008

  Wenzel, Sally E ^a   Schwartz, Lawrence B ^b   Langmack, Esther L ^b   Halliday, Janet L ^b   Trudeau, John B ^b   Gibbs, Robyn L ^b   Chu, Hong Wei ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID;

ADULT; ALLERGY TEST; ARTICLE; ASTHMA; BIOPSY; CELL TYPE; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAL CAPACITY;

EID: 0032875377     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9812110     Document Type: Article

References (34)

1. Weiss, K. B., P. J. Gergen, and T. A. Hodgson. 1992. An economic evaluation of asthma in the United States. N. Engl. J. Med. 862-866.
2. Wenzel, S. E., S. J. Szefler, D. Y. M. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin, 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am. J. Respir. Crit. Care Med. 156:737-743.
3. Schleimer, R. P., H. S. Freeland, S. P. Peters, K. E. Brown, and C. P. Derse. 1989. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J. Pharm. Exp. Ther. 250:598-605.
4. Leung, D. Y. M., R. J. Martin, S. J. Szefler, L. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181:33-40.
5. Adcock, I. M., S. J. Lane, C. R. Brown, I. H. Lee, and P. J. Barnes. 1995. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J. Exp. Med. 182:1951-1958.
6. Cho, S. H., J. Y. Seo, D. C. Choi, H. J. Yoon, Y. J. Cho, K. U. Min, G. K. Lee, J. W. Seo, and Y. Y. Kim. 1996. Pathological changes according to the severity of asthma. Clin. Exp. Allergy 26:1210-1219.
7. Chetta, A., A. Foresi, M. D. Donno, G. Bertorelli, A. Pesci, and D. Olivieri. 1997. Airway remodeling is a distinctive feature of asthma and is related to severity of asthma. Chest 111:852-857.
8. Chu, H. W., J. L. Halliday, R. J. Martin, D. Y. M. Leung, S. J. Szefler, and S. E. Wenzel. 1998. Collagen deposition in large airways does not appear to differentiate severe asthma from milder forms of the disease. Am. J. Respir. Crit. Care Med. 158:1936-1444.
9. American College of Chest Physicians-American Thoracic Society (ACCP-ATS), Committee J, Nomenclature P. 1975. Pulmonary terms and symbols: a report of the the ACCP-ATS Joint Committee on Pulmonary Nomenclature. Chest 67:583-593.
10. Chan, M. T. S., D. Y. M. Leung, S. J. Szefler, and J. D. Spahn. 1998. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J. Allergy Clin. Immunol. 101:594-601.
11. Enander, I., P. Matsson, J. Nystrand, A. S. Andersson, E. Eklund, T. R. Bradford, and L. B. Schwartz. 1991. A new radioimmunoassay for human mast cell tryplase using monoclonal antibodies. J. Immunol. Methods 138:39-16.
12. Wenzel, S. E., A. A. I. Fowler, and L. B. Schwartz. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am. Rev. Respir. Dis. 137:1002-1008.
13. Schwartz, L. B., T. R. Bradford, C. Rouse, A.-M. Irani, G. Rasp, J. K. Van der Zwan, and P.-W. G. Van der Linden. 1994. Development of a new more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 14:190-204.
14. Daniel, W. W. 1990, Applied Nonparametric Statistics, 2nd ed. PSW, Kent.
15. Singulair. Package Insert.
16. Laitinen, L. A., I. P. Naya, S. Binks, and A. Harris. 1997. Comparative efficacy of zafirlukast and low dose steroids in asthmatics on prn β2-agonists. Eur. Respir. J. 10:419S.
17. Vignola, A. M., P. Chancz, A. M. Campbell, F. Souques, B. Lebel, I. Enander, and J. Bousquet. 1998. Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157:403-409.
18. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
19. Djukanovic, R., C. K. W. Lai, J. W. Wilson, K. M. Britten, S. J. Wilson, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls, Eur. Respir. J. 5:538-544.
20. Bentley, A. M., O. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
21. Bradley, B. L., M. Azzawi, M. Jacobson, H. Assoufi, J. V. Collins, A.-M. A. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88:661-674.
22. Walker, C., E. Bose, L. Boer, T. T. Hansel, K. Blaser, and J.-C. Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
23. Humbert, M., J. A. Grant, L. Taborda-Barata, S. R. Durham, R. Pfister, G. Menz, J. Barkans, S. Ying, and A. B. Kay. 1996, High affinity IgE receptor (FecRI)-bearing ceils in bronchial biopsies from atopic and non-atopic asthma. Am. J. Respir. Crit. Care Med. 153:1931-1937.
24. Humbert, M., S. R. Durham, S. Ying, P. Kimmitt, J. Barkans, B. Assouli, R. Pfistcr, G. Menz, D. S. Robinson, A. B. Kay, and C. J. Corrigan. 1996. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am. J. Respir. Crit. Care Med. 154:1497-1504.
25. Crimi, E., A. Spancvello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157:4-9.
26. Martin, R. J., L. C. Cicutto, H. K. Smith, K. D. Ballard, and S. J. Szefler. 1991. Airways inflammation in nocturnal asthma. Am. Rev. Respir. Dis. 143:351-357.
27. Fahy, J. V., K. W. Kim, and J. Liu. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
28. Lamblin, C., P. Gosset, I. Tillie-Leblond, F. Saulnier, C-H. Marquette, B. Wallaert, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus, Am. J. Respir. Crit. Care Med. 157:394-402.
29. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, G. J. Gleich. 1993. Sudden-onset fatal asthma - a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148:713-719.
30. Minshall, E. M., D. Y. M. Leung , R. J. Martin, Y. L. Song, L. Cameron, P. Ernst, and Q. Hamid. 1997. Eosinophil-associated TGF-β1 mRNA expression and airway fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326-333.
31. Liu, A. H., S. M. Brugman, E. B. Schaeffer, and C. G. Irvin. 1990. Reduced lung elasticity may characterize children with severe asthma. Am. Rev. Respir. Dis. 141:A906.
32. Erzurum, S. C., J. A. Leff, J. E. Cochran, L. M. Ackerson, S. J. Szefler, R. J. Martin, and G. R. Cott. 1991. Lack of benefit of methotrexate in severe, steroid-dependent asthma. Ann. Intern. Med. 114:353-360.
33. Lock, S. H., A. B. Kay, and N. C. Barnes. 1996. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 153:509-514.
34. Bernstein, I. L., D. I. Bernstein, and J. W. Dubb. 1996. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-depcndent asthma. J. Allergy Clin. Immunol. 98:317-324.